Avanza Fonder Ab Bridge Bio Pharma, Inc. Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 6,121 shares of BBIO stock, worth $233,944. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,121
Previous 6,581
6.99%
Holding current value
$233,944
Previous $181 Million
17.35%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
330Shares Held
182MCall Options Held
12.7MPut Options Held
2.46M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$965 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$960 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$569 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$476 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$236 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.67B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...